Studien

AVOID

Aliskiren in the eValuation of PrOteinuria in Diabetes

AVOID

Australian Air Versus Oxygen In myocarDial infarction

AVOID-HF

Heart Failure hospitalizations after aquapheresis therapy compared to intravenous (IV) diuretic treatment

AVOREN

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma

AVULS

Ambulatory Varicosity avUlsion Later or Synchronised

AVURT

Aspirin for Venous Ulcers: Randomised Trial

AWAKE-HF

Study on the Effects of Sacubitril/​Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients

AWARD-1

Assessment of Weekly Administration of LY2189265 [dulaglutide] in Diabetes-1

AWARD-10

Assessment of Weekly Administration of LY2189265 [dulaglutide] in Diabetes-10

AWARD-11

Assessment of Weekly Administration of LY2189265 [dulaglutide] in Diabetes-11

AWARD-2

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-2

AWARD-3

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-3

AWARD-4

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-4

AWARD-5

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-5

AWARD-6

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-6

AWARD-7

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-7

AWARD-8

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-8

AWARD-9

Assessment of Weekly AdministRation of LY2189265 [dulaglutide] in Diabetes-9

AWARD-CHN1

A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus

AWARD-PEDS

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

AWARE

Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization

AWARE

Assessment of Worldwide Acute kidney Injury, Renal agina, and Epidemiology

AWARE

Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence

AWARE

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis

AWARE

HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.

AWARE

School-based intervention study examining approaches for well-being and mental health literacy of pupils in Year 9 in England

AWED

Applying Wolbachia to Eliminate Dengue

AWESOME

Angina With Extremely Serious Operative Mortality Evaluation

AwM

Act when Mild

AXA

AXA, Paris La Défense, France

AXADIA-AFNET 8

Compare Apixaban and Vitamin K Antagonists in Patients With Atrial Fibrillation and End-Stage Kidney Disease

AXAFA biomolecule

Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation

AXAFA-AFNET 5

An Investigator-Initiated, Randomized, Open, Blinded Outcome Assessment, Multi-Centre Trial to Comparing Continuous Apixaban to Vitamin K Antagonists in Patients Undergoing Atrial Fibrillation Catheter Ablation

AXaLPE

Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients

AXEPT

Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer

AXIOMATIC-SSP

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

AXIOMATIC-TKR

A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery

AXIS

Adjuvant X-ray and fluorouracil Infusion Study

AXIS

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

AXIS

Treatment With AX200 for Acute Ischemic Stroke

AXSANA EUBREAST 3

AXillary Surgery After NeoAdjuvant Treatment

AYAME

A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

AYAME

Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease

AZ HEROES

Arizona Healthcare, Emergency Response, and Other Essential workers Study

AZ-OC

Academisch Ziekenhuis Oncologic Centre (Vrije Universiteit Brussels)

AZACS

Azithromycin in Acute Coronary Syndrome

AZALEA

Azithromycin Against Placebo in Exacerbations of Asthma

AZALEA-TIMI 71

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

AZIQUINE-ICU

Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)

AZISAST

AZIthromycin for prevention of exacerbations in Severe ASThma

AZTEC

Azithromycin therapy for chronic lung disease of prematurity

AZURE

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

AZURE (BIG 01/04)

Adjuvant Zoledronic acid to redUce REcurrence

AZUREA

Lung Imaging for Ventilatory Setting in ARDS

AβYSS

Beta Blocker Interruption After Uncomplicated Myocardial Infarction

B-Clear

A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)

B-CONVINCED

Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode

B-FAST

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

B-LEFT HF

Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients

B-LEFT HF

Biventricular vs. left univentricular pacing with ICD back-up in heart failure patients